O74 Epoxyeicosatrienoic Acids Analogue (Eet-A) for the Treatment of Chemotherapy-Induced Heart Failure With Nephrotic Syndrome

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1CYP2J2-derived epoxyeicosatrienoic acids protect against doxorubicin-induced cardiotoxicity by reducing oxidative stress and apoptosis via activation of the AMPK pathway2023 · 5 citations
2. 2Epoxyeicosatrienoic acid analog attenuates the development of malignant hypertension, but does not reverse it once established2016 · 25 citations
3. 3Unleashing the cardioprotective potential of Ezetimibe against Doxorubicin-induced cardiotoxicity in Wistar rats: Targeting oxidative stress and NF-κB-mediated inflammation2024 · 1 citations
4. 4Characterization of a new model of chemotherapy-induced heart failure with reduced ejection fraction and nephrotic syndrome in Ren-2 transgenic rats2024 · 5 citations
5. 5Inhibition of Soluble Epoxide Hydrolase Does Not Improve the Course of Congestive Heart Failure and the Development of Renal Dysfunction in Rats With Volume Overload Induced by Aorto-Caval Fistula2015 · 29 citations